121 related articles for article (PubMed ID: 18306371)
41. Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis.
Jäger K; Larribère L; Wu H; Weiss C; Gebhardt C; Utikal J
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30641895
[TBL] [Abstract][Full Text] [Related]
42. Gender differences, UV exposure and risk of lentigo maligna in a nationwide healthcare population cohort study.
Higgins HW; Cho E; Weinstock MA; Li TY; Qureshi A; Li WQ
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1268-1271. PubMed ID: 30451319
[TBL] [Abstract][Full Text] [Related]
43. Disparities in diagnosis of advanced melanoma: a population-based cohort study.
Mavor ME; Richardson H; Miao Q; Asai Y; Hanna TP
CMAJ Open; 2018; 6(4):E502-E512. PubMed ID: 30381323
[TBL] [Abstract][Full Text] [Related]
44. Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis.
Ecker BL; Kaur A; Douglass SM; Webster MR; Almeida FV; Marino GE; Sinnamon AJ; Neuwirth MG; Alicea GM; Ndoye A; Fane M; Xu X; Sim MS; Deutsch GB; Faries MB; Karakousis GC; Weeraratna AT
Cancer Discov; 2019 Jan; 9(1):82-95. PubMed ID: 30279172
[TBL] [Abstract][Full Text] [Related]
45. Outcomes and Risk Factors in Patients with Multiple Primary Melanomas.
Nosrati A; Yu WY; McGuire J; Griffin A; de Souza JR; Singh R; Linos E; Chren MM; Grimes B; Jewell NP; Wei ML
J Invest Dermatol; 2019 Jan; 139(1):195-201. PubMed ID: 30031745
[TBL] [Abstract][Full Text] [Related]
46. Integrative Genome-Wide Analysis of Long Noncoding RNAs in Diverse Immune Cell Types of Melanoma Patients.
Wang L; Felts SJ; Van Keulen VP; Scheid AD; Block MS; Markovic SN; Pease LR; Zhang Y
Cancer Res; 2018 Aug; 78(15):4411-4423. PubMed ID: 29895674
[TBL] [Abstract][Full Text] [Related]
47. High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry.
Robsahm TE; Helsing P; Nilssen Y; Vos L; Rizvi SMH; Akslen LA; Veierød MB
Clin Epidemiol; 2018; 10():537-548. PubMed ID: 29780262
[TBL] [Abstract][Full Text] [Related]
48. Enhanced expression of PD-1 and other activation markers by CD4+ T cells of young but not old patients with metastatic melanoma.
van den Brom RRH; van der Geest KSM; Brouwer E; Hospers GAP; Boots AMH
Cancer Immunol Immunother; 2018 Jun; 67(6):925-933. PubMed ID: 29546435
[TBL] [Abstract][Full Text] [Related]
49. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.
Li B; Wang Y; Xu Y; Liu H; Bloomer W; Zhu D; Amos CI; Fang S; Lee JE; Li X; Han J; Wei Q
Int J Cancer; 2018 Jun; 142(11):2303-2312. PubMed ID: 29313974
[TBL] [Abstract][Full Text] [Related]
50. Effect of biology on the outcome of female melanoma patients.
Erturk K; Tas F
Mol Clin Oncol; 2017 Dec; 7(6):1093-1100. PubMed ID: 29285381
[TBL] [Abstract][Full Text] [Related]
51. Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients.
Morgese F; Soldato D; Pagliaretta S; Giampieri R; Brancorsini D; Torniai M; Rinaldi S; Savini A; Onofri A; Scarpelli M; Berardi R
Oncotarget; 2017 Sep; 8(44):75914-75923. PubMed ID: 29100280
[TBL] [Abstract][Full Text] [Related]
52. Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology.
Garcovich S; Colloca G; Sollena P; Andrea B; Balducci L; Cho WC; Bernabei R; Peris K
Aging Dis; 2017 Oct; 8(5):643-661. PubMed ID: 28966807
[TBL] [Abstract][Full Text] [Related]
53. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
Enninga EAL; Moser JC; Weaver AL; Markovic SN; Brewer JD; Leontovich AA; Hieken TJ; Shuster L; Kottschade LA; Olariu A; Mansfield AS; Dronca RS
Cancer Med; 2017 Oct; 6(10):2203-2212. PubMed ID: 28879661
[TBL] [Abstract][Full Text] [Related]
54. Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.
Kromer C; Xu J; Ostrom QT; Gittleman H; Kruchko C; Sawaya R; Barnholtz-Sloan JS
J Neurooncol; 2017 Aug; 134(1):55-64. PubMed ID: 28567587
[TBL] [Abstract][Full Text] [Related]
55. Trends in mortality rates of cutaneous melanoma in East Asian populations.
Chen L; Jin S
PeerJ; 2016; 4():e2809. PubMed ID: 28028475
[TBL] [Abstract][Full Text] [Related]
56. Impact of gender and primary tumor location on outcome of patients with cutaneous melanoma.
Voinea S; Blidaru A; Panaitescu E; Sandru A
J Med Life; 2016; 9(4):444-448. PubMed ID: 27928453
[No Abstract] [Full Text] [Related]
57. Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.
Schoffer O; Schülein S; Arand G; Arnholdt H; Baaske D; Bargou RC; Becker N; Beckmann MW; Bodack Y; Böhme B; Bozkurt T; Breitsprecher R; Buchali A; Burger E; Burger U; Dommisch K; Elsner G; Fernschild K; Flintzer U; Funke U; Gerken M; Göbel H; Grobe N; Gumpp V; Heinzerling L; Kempfer LR; Kiani A; Klinkhammer-Schalke M; Klöcking S; Kreibich U; Knabner K; Kuhn P; Lutze S; Mäder U; Maisel T; Maschke J; Middeke M; Neubauer A; Niedostatek A; Opazo-Saez A; Peters C; Schell B; Schenkirsch G; Schmalenberg H; Schmidt P; Schneider C; Schubotz B; Seide A; Strecker P; Taubenheim S; Wackes M; Weiß S; Welke C; Werner C; Wittekind C; Wulff J; Zettl H; Klug SJ
BMC Cancer; 2016 Dec; 16(1):936. PubMed ID: 27919243
[TBL] [Abstract][Full Text] [Related]
58. The influence of tumor regression, solar elastosis, and patient age on pathologists' interpretation of melanocytic skin lesions.
Titus L; Barnhill RL; Lott JP; Piepkorn MW; Elder DE; Frederick PD; Nelson HD; Carney PA; Knezevich SR; Weinstock MA; Elmore JG
Lab Invest; 2017 Feb; 97(2):187-193. PubMed ID: 27892931
[TBL] [Abstract][Full Text] [Related]
59. Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.
Weiss SA; Han J; Darvishian F; Tchack J; Han SW; Malecek K; Krogsgaard M; Osman I; Zhong J
J Transl Med; 2016 Oct; 14(1):299. PubMed ID: 27760559
[TBL] [Abstract][Full Text] [Related]
60. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
